Howard H Feldman

10PUBLICATIONS
46CO-AUTHORS
Neurology and neuromuscular diseasesCentral nervous systemHealth promotionMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 10, 2026
Safety considerations of gene-based therapies for Alzheimer's disease.

|Jan 19, 2026
Genetics and Brain Health in Adults With Congenital Heart Disease: A Consensus Statement From the ACHD/Neuro 2024 Conference.

Thalia S Field, Sarah U Morton, Marie Brossard-Racine

|Nov 24, 2025
Exploring the usability and perceived benefits of Brain Health PRO: An online educational program for healthy brain aging.

George Philip, Alexandra J Fiocco, Sylvie Belleville

|Dec 13, 2024
Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease.

Joshua D Grill, Steven Tam, Gaby Thai

|Sep 24, 2024
A framework for translating tauopathy therapeutics: Drug discovery to clinical trials.

Howard H Feldman, Jeffrey L Cummings, Adam L Boxer

|May 29, 2024
Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam).

Howard H Feldman, José A Luchsinger, Gabriel C Léger

Pageof 2

Frequent Collaborators

3 joint publications

Haakon B Nygaard

2 joint publications

David Yang

2 joint publications

Ging-Yuek R Hsiung

2 joint publications

John R Best